Literature DB >> 30733904

Mathematical Models for Tumor Growth and the Reduction of Overtreatment.

Berdine L Heesterman1, John-Melle Bokhorst1, Lisa M H de Pont1, Berit M Verbist2, Jean-Pierre Bayley3, Andel G L van der Mey1, Eleonora P M Corssmit4, Frederik J Hes5, Peter Paul G van Benthem1, Jeroen C Jansen1.   

Abstract

Background  To improve our understanding of the natural course of head and neck paragangliomas (HNPGL) and ultimately differentiate between cases that benefit from early treatment and those that are best left untreated, we studied the growth dynamics of 77 HNPGL managed with primary observation. Methods  Using digitally available magnetic resonance images, tumor volume was estimated at three time points. Subsequently, nonlinear least squares regression was used to fit seven mathematical models to the observed growth data. Goodness of fit was assessed with the coefficient of determination ( R 2 ) and root-mean-squared error. The models were compared with Kruskal-Wallis one-way analysis of variance and subsequent post-hoc tests. In addition, the credibility of predictions (age at onset of neoplastic growth and estimated volume at age 90) was evaluated. Results  Equations generating sigmoidal-shaped growth curves (Gompertz, logistic, Spratt and Bertalanffy) provided a good fit (median R 2 : 0.996-1.00) and better described the observed data compared with the linear, exponential, and Mendelsohn equations ( p  < 0.001). Although there was no statistically significant difference between the sigmoidal-shaped growth curves regarding the goodness of fit, a realistic age at onset and estimated volume at age 90 were most often predicted by the Bertalanffy model. Conclusions  Growth of HNPGL is best described by decelerating tumor growth laws, with a preference for the Bertalanffy model. To the best of our knowledge, this is the first time that this often-neglected model has been successfully fitted to clinically obtained growth data.

Entities:  

Keywords:  carotid body tumors; growth; mathematics; models; paragangliomas; vagal body

Year:  2018        PMID: 30733904      PMCID: PMC6365230          DOI: 10.1055/s-0038-1667148

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  31 in total

1.  Observations on growth rates of human tumors.

Authors:  V P COLLINS; R K LOEFFLER; H TIVEY
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1956-11

2.  Growth curve analysis of asymptomatic and symptomatic meningiomas.

Authors:  Satoshi Nakasu; Yoko Nakasu; Tadateru Fukami; Junya Jito; Kazuhiko Nozaki
Journal:  J Neurooncol       Date:  2010-08-05       Impact factor: 4.130

3.  Enhancing renal tumors in patients with prior normal abdominal imaging: further insight into the natural history of renal cell carcinoma.

Authors:  Paul L Crispen; Aldiana Soljic; Gregory Stewart; Alexander Kutikov; Daniel Davenport; Robert G Uzzo
Journal:  J Urol       Date:  2012-08-15       Impact factor: 7.450

4.  Growth rate of new hepatocellular carcinoma after percutaneous radiofrequency ablation: evaluation with multiphase CT.

Authors:  Yulri Park; Dongil Choi; Hyo K Lim; Hyunchul Rhim; Young-Sun Kim; Seong Hyun Kim; Won Jae Lee
Journal:  AJR Am J Roentgenol       Date:  2008-07       Impact factor: 3.959

5.  Growth modelling of non-functioning pituitary adenomas in patients referred for surgery.

Authors:  Juergen Honegger; Sanna Zimmermann; Tsambika Psaras; Manfred Petrick; Michel Mittelbronn; Ulrike Ernemann; Martin Reincke; Klaus Dietz
Journal:  Eur J Endocrinol       Date:  2008-03       Impact factor: 6.664

6.  Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

Authors:  Gerrit Draisma; Ruth Etzioni; Alex Tsodikov; Angela Mariotto; Elisabeth Wever; Roman Gulati; Eric Feuer; Harry de Koning
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

7.  The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family.

Authors:  Erik F Hensen; Jeroen C Jansen; Maaike D Siemers; Jan C Oosterwijk; Annette Hjt Vriends; Eleonora Pm Corssmit; Jean-Pierre Bayley; Andel Gl van der Mey; Cees J Cornelisse; Peter Devilee
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

8.  High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.

Authors:  Berdine L Heesterman; Jean Pierre Bayley; Carli M Tops; Frederik J Hes; Bernadette T J van Brussel; Eleonora P M Corssmit; Jaap F Hamming; Andel G L van der Mey; Jeroen C Jansen
Journal:  Eur J Hum Genet       Date:  2012-09-05       Impact factor: 4.246

9.  Paragangliomas and paraganglioma syndromes.

Authors:  Carsten Christof Boedeker
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

10.  DYNAMICS OF TUMOR GROWTH.

Authors:  A K LAIRD
Journal:  Br J Cancer       Date:  1964-09       Impact factor: 7.640

View more
  2 in total

1.  Universal scaling laws rule explosive growth in human cancers.

Authors:  Víctor M Pérez-García; Gabriel F Calvo; Jesús J Bosque; Odelaisy León-Triana; Juan Jiménez; Julián Perez-Beteta; Juan Belmonte-Beitia; Manuel Valiente; Lucía Zhu; Pedro García-Gómez; Pilar Sánchez-Gómez; Esther Hernández-San Miguel; Rafael Hortigüela; Youness Azimzade; David Molina-García; Álvaro Martinez; Ángel Acosta Rojas; Ana Ortiz de Mendivil; Francois Vallette; Philippe Schucht; Michael Murek; María Pérez-Cano; David Albillo; Antonio F Honguero Martínez; Germán A Jiménez Londoño; Estanislao Arana; Ana M García Vicente
Journal:  Nat Phys       Date:  2020-08-10       Impact factor: 20.034

2.  Understanding the effect of measurement time on drug characterization.

Authors:  Hope Murphy; Gabriel McCarthy; Hana M Dobrovolny
Journal:  PLoS One       Date:  2020-05-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.